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Summary Guideline adherence of general practition-
ers (GP) regarding treatment of chronic conditions
shows room for improvement. Thus, concepts have
to be designed to promote quality of care. The aim of
the interventional study “Improvement of Quality by
Benchmarking” was to assess whether quality can be
improved by self-auditing, benchmarking and quality
circles in Salzburg (Austria) and South Tyrol (Italy). In
this publication we present the Austrian results. Qual-
ity indicators were developed in a consensus process
for eight chronic diseases based on pre-existing qual-
ity management systems. A quality score consisting of
35 indicators was calculated (0–5 points per indicator
depending on fulfilment, maximum 175 points). Data
were extracted from the electronic health records
of participating practices in 2012, 2013 and 2014.
A statistical pre-post analysis was performed using
Wilcoxon signed-rank tests. A total of 20 GPs partici-
pated in the project. The mean quality score increased
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from 62.0 at baseline to 84.0 at the second follow-up
(p = 0.003). Regarding the individual quality indi-
cators, strong improvements were achieved between
baseline and first follow-up, especially in process indi-
cators concerning documentation. Between the first
and second follow-up, quality remained in most cases
at the same level. The validity of results is limited
because of structural and technical problems. Due to
the uncontrolled pre-post design we cannot exclude
external influences on the results. Nevertheless, the
intervention was able to improve measured quality of
care. Barriers were detected that should be consid-
ered in a possible implementation of quality control
programs.
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Abbreviations
ACE-I Angiotensin-converting enzyme inhibitor
AF Atrial fibrillation
ARB Angiotensin receptor blocker
ATC Anatomical therapeutic chemical classifica-
tion system
BMI Body mass index
CBVD Cerebrovascular disease
CHD Coronary heart disease
CHF Chronic heart failure
COPD Chronic obstructive pulmonary disease
DM Diabetes mellitus type 2
DMP Disease management program
EHR(s) Electronic health record(s)
GP(s) General practitioner(s)
HT Hypertension
NHS National Health Service
PAD Peripheral arterial occlusive disease
QI(s) Quality indicator(s)
QOF Quality and outcomes framework
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SIMG Societá Italiana Medicina Generale (Italian
Society of General Medical Practice)
Introduction
Chronic conditions are the most important cause of
illness and disability in Europe and place a high fi-
nancial demand on healthcare systems [1]. Medical
care of patients with chronic diseases is often chal-
lenging and requires coordinated follow-up, which is
usually assured by general practitioners (GP) [2]. Nev-
ertheless, patients with chronic conditions are not al-
ways appropriately treated and guideline adherence
of GPs leaves room for improvement [3, 4]. For ex-
ample, an Austrian cross-sectional study assessing 9
quality indicators in 501 patients with chronic dis-
eases detected non-adherence to guidelines in 16.8%
of the 1224 quality indicators which could be applied,
mostly due to physicians’ lack of knowledge [3]. An-
other study found that only 29.3% of patients with
chronic heart failure were treated with beta blockers
and only 35.6% of those patients receiving ACE-I were
prescribed the recommended daily dose [4].
A key role is played by GPs in quality improvement
in the healthcare system [2] as quality enhancement
has been defined as an essential topic of general prac-
tice [5]. Regarding the approach strategies of quality
improvement in outpatient care, several methods ex-
ist: for instance, quality circles consist of small groups
of GPs who meet regularly to find solutions purpose-
fully and autonomously for occurring problems [6].
They are an accepted instrument for GPs and have
been shown to make an impact on care outcomes
[7]. Peer reviews are critical (self-)reflections of medi-
cal actions in the dialogue with colleagues within the
same discipline. The term peer review was originally
used as a synonym for quality circles [6]. (Self-)au-
dits consist of a systematic and critical evaluation of
quality in a GP’s surgery performed by external physi-
cians or by reflection of data by the physicians them-
selves, based on the available evidence or accepted
consensus guidelines [8]. Another approach to im-
prove quality is benchmarking, which is a compara-
tive method measuring and ranking performance in-
dicators [6]. Overall, analysis of systematic reviews
shows that combined and multifaceted interventions
with educational components are more effective [9].
Quality indicators (QI) have been a topic of increas-
ing interest over the last decades enabling conclusions
on current quality and on improving opportunities.
They were defined by Lawrence and Olesen [10] as
“a measurable element of practice performance for
which there is evidence or consensus that it can be
used to assess the quality, and hence change in the
quality of care provided”. Concepts using QIs have
been established in several countries. For instance, in
Germany, the quality indicator system for outpatient
treatment project (Qualitätsindikatorensystem für die
ambulante Versorgung, QISA) uses a set of QIs in pri-
mary care for promoting transparency of quality [11],
while in the UK the quality and outcomes framework
(QOF) has been used since 2004 as a pay for perfor-
mance scheme based on a large number of QIs for
several chronic conditions, organization of care and
patient experiences [12], generating payments accord-
ing to the quality standards achieved. In Italy, qual-
ity assessments with process and intermediate out-
come indicators are performed by Health Search (re-
search unit of the Italian Society of General Practice,
SIMG) providing a network of GPs the possibility to
perform self-audits and to benchmark their perfor-
mance with other GPs [13]. In Austrian primary care,
an established systematic quality enhancement ap-
proach based on QIs does not yet exist, although qual-
ity improvement in healthcare has become an impor-
tant field of political interest in recent years [14].
Against this background, the present study called
„Improvement of Quality by Benchmarking“ (IQuaB)
was started as a transnational quality improving initia-
tive of GPs in Salzburg (Austria) and South Tyrol (Italy)
with the aim to assess quality of care of patients with
eight chronic diseases by a quality score and by item-
ized QIs in general practice surgeries and to assess
whether the quality of healthcare can be improved by
a combined intervention consisting of self-auditing,
benchmarking and quality circles within 18 months.
In this article we present the Austrian results. The
Italian data and the comparison between the two re-
gions will be reported elsewhere.
Methods
The study was conducted as an uncontrolled inter-
ventional study between October 2011 and Septem-
ber 2014 in two study regions, two counties of the
province of Salzburg, Austria and the province of
South Tyrol, Italy.
GP recruitment
As this was designed as a pre-post study, no sample
size calculation was performed. We aimed at recruit-
ing 30 GPs. All practicing family physicians were con-
sidered to be eligible if they were working alone or
in group practices in primary care in the counties of
Pinzgau or Pongau (Salzburg, Austria); therefore, all
GPs with an address in the specified regions regis-
tered at the Salzburg Medical Chamber with or with-
out a contract with the statutory health insurance (n =
114 GP practices including 133 GPs) were invited to
participate by letter, email or telephone. Physicians
were remunerated for participation.
Development of QIs and quality standards
QIs were developed in a consensus process by screen-
ing several guidelines [15–18] and by adapting perfor-
mance indicators used by Health Search [13] and in
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the QOF [19]; the following QIs were used in the IQuaB
project: prevalences of diseases, recording of BMI,
recording of blood pressure, registration of smok-
ing behavior, creatinine measurement, glycosylated
haemoglobin (HbA1c) measurement, HbA1c < 7.5%,
documentation of spirometry, metformin prescrip-
tion, statin prescription, beta blocker prescription,
ACE-I/ARB prescription, prescription of antithrom-
botic therapy. Several of these QIs were applied more
than once because they were applicable to more than
one of the eight targeted diseases. This resulted in a
total number of 43 QIs (see Table 1). Several partici-
pating physicians were involved in the development
process to assure the acceptance of the QIs by GPs
and the feasibility of data extraction from the elec-
tronic health records (EHRs). The low number of QIs
in comparison to e. g. the QOF indicators was due
to the limited feasibility of extracting and measuring
indicators in the EHRs used in Austria. Object of the
investigation was the quality of care regarding eight
common chronic diseases in general practice: type 2
diabetes mellitus (DM), hypertension (HT), coronary
heart disease (CHD), cerebrovascular disease (CBVD),
peripheral arterial disease (PAD), chronic heart failure
(CHF), atrial fibrillation (AF) and chronic obstructive
pulmonary disease (COPD). The indicators provided
information about the prevalence of the diseases,
documentation process, diagnostic tests and medical
therapy. Time intervals for the single QIs were defined
as a determined time period in which the respective
documentation, diagnostic test or prescription should
be performed, including an additional quarter year
as the range of tolerance. As patients with chronic
diseases usually visit their GP at least once a year,
prevalence rates were defined (for data extraction) as
the percentage of patients with a specific condition
who visited the GP within the last 15 months, in re-
lation to the total number of patients treated in the
same time period by the respective GP. Since this re-
flects the prevalence among patients who visit the GP
at least once in 15 months and not the prevalence in
the general population, for data analysis the extracted
prevalence rates were adjusted for the proportion of
patients who do not visit the GP regularly according to
results of the Austrian Health Survey 2006/2007 [20].
Time intervals for QIs regarding drug prescriptions
were 3 months as the investigated chronic conditions
usually require uninterrupted therapy. Exception was
the prescription of antiplatelet and anticoagulant
drugs, for which an 8-month prescription interval
was chosen because of low dosage intakes and large
package sizes.
In the participating surgeries, five different EHRs
were in use that provided restricted possibilities to
extract data; therefore, only the limited number of 43
QIs could be applied. The achievement regarding a QI
was defined as the percentage of patients who fulfilled
the respective criterion in relation to the total number
of patients with the concerning diagnosis. Exceptions
were HbA1c values < 7.5% and metformin prescrip-
tions if HbA1c ≥ 7.5%, which depended on the diag-
nosis and on another QI: the indicator HbA1c < 7.5%
was determined as the percentage of patients who had
an HbA1c value below target in relation to the total
number of patients with DM who had an HbA1c mea-
surement. The QI metformin prescriptions if HbA1c
≥ 7.5% was determined as the percentage of patients
who had a metformin prescription in relation to all
patients with DM who had an HbA1c measurement
and a value above the target value.
For each indicator, quality standards (acceptable
and ideal level of performance) were defined, describ-
ing the frequency with which the QI criterion should
be attained [10]. As evidence-based quality standards
do not exist, target values used in our study were de-
termined in a consensus process based on the target
values used by Health Search1 [13] and on the QOF
payment stages [19]. All QIs and their respective tar-
get values are listed in Table 1.
Data collection
Data extraction was performed in June–September
2012, April–June 2013 and January–April 2014. Physi-
cians’ data were retrieved but not individual patient
data (e. g. number of patients with diabetes and regis-
tration of smoking behavior per GP). The project staff
conducted the extraction of data manually in the GP
practices. As diagnoses are usually not coded in Aus-
trian general practices and are recorded in the EHR
as string variables, GPs were asked to standardize the
terminology of diagnoses (e. g. DM2 instead of type 2
diabetes mellitus) to simplify the search. Also medi-
cations are not usually recorded using ATC codes and
were therefore searched via brand names as strings. It
was not feasible to retrieve medication plans for long-
term drug treatment from the EHR in all surgeries
because they were not consistently entered by GPs.
Hence, in many cases, single prescriptions within
the respective predetermined time-range had to be
extracted. Laboratory values, smoking behavior and
blood pressure also had to be searched using strings
in most cases because the data and measurements
were not recorded in standardized data fields.
The five EHR systems required different search
strategies and enabled various degrees of data extrac-
tion. In EHR 1, entering multiple search terms was
not possible and each medication had to be searched
1 Target values from Health Search (ideal and acceptable level of
performance) are based on the actual levels of performance of
GPs measured by Health Search and on an estimated maximum
of percentage achievable for each indicator, considering specific
problems not depending on the GP’s purpose or knowledge (e. g.
known % of contraindications or intolerances of drugs, probabil-
ity of patients’ refusal). This approach offers to GPs the possibil-
ity to identify strengths and weaknesses in their care, although
the target levels are disputable for being partially arbitrary and
they may not make claim for completeness [13].
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Table 1 Quality indicators andquality standards (acceptable and ideal level of performance) used in the IQuaBproject
No. Acceptable (%) Ideal (%)
Diabetes mellitus type 2
1 Prevalence 4.5 7
2 Body mass index (recorded within last 15 months) 80.0 100.0
3 Blood pressure (recorded within last 15 months) 70.0 100.0
4 Registration of smoking behavior (smoker or non-smoker) 80.0 100.0
5 Creatinine measurement (done within last 15 months) 80.0 100.0
6 HbA1c measurement (done within last 9 months) 60.0 90.0
7 HbA1c < 7.5% (any value within last 9 months) 70.0 90.0
8 Metformin prescription (within last 3 months) if HbA1c ≥ 7.5% (any value within last 9 months) 70.0 90.0
Hypertension
9 Prevalence 20.0 30.0
10 Body mass index (recorded within last 15 months) 80.0 100.0
11 Blood pressure (recorded within last 15 months) 70.0 100.0
12 Registration of smoking behavior (smoker or non-smoker) 80.0 100.0
13 Creatinine measurement (done within last 15 months) 80.0 100.0
Coronary heart disease
14 Prevalence 2.0 2.5
15 Body mass index (recorded within last 15 months) 80.0 100.0
16 Blood pressure (recorded within last 15 months) 70.0 100.0
17 Registration of smoking behavior (smoker or non-smoker) 80.0 100.0
18 Statin prescription (within last 3 months) 80.0 90.0
19 Beta-blocker prescription (within last 3 months) 80.0 90.0
20 Prescription of antithrombotic therapy (within last 8 months) 80.0 90.0
Cerebrovascular disease
21 Prevalence 2.0 2.0
22 Body mass index (recorded within last 15 months) 80.0 100.0
23 Blood pressure (recorded within last 15 months) 70.0 100.0
24 Registration of smoking behavior (smoker or non-smoker) 80.0 100.0
25 Statin prescription (within last 3 months) 80.0 90.0
26 Prescription of antithrombotic therapy (within last 8 months) 80.0 90.0
Peripheral arterial disease
27 Prevalence 2.0 3.0
28 Body mass index (recorded within last 15 months) 80.0 100.0
29 Blood pressure (recorded within last 15 months) 70.0 100.0
30 Registration of smoking behavior (smoker or non-smoker) 80.0 100.0
31 Statin prescription (within last 3 months) 80.0 90.0
32 Prescription of antithrombotic therapy (within last 8 months) 80.0 90.0
Chronic heart failure
33 Prevalence 1.5 3.0
34 Body mass index (recorded within last 15 months) 80.0 100.0
35 Blood pressure (recorded within last 15 months) 70.0 100.0
36 ACE-I or ARB prescription (within last 3 months) 80.0 90.0
37 Beta-blocker prescription (within last 3 months) 80.0 90.0
Atrial fibrillation
38 Prevalence 2.0 2.0
39 Blood pressure (recorded within last 15 months) 70.0 100.0
40 Prescription of antithrombotic therapy (within last 8 months) 80.0 90.0
Chronic obstructive pulmonary disease
41 Prevalence 2.5 5.0
42 Registration of smoking behavior (smoker or non-smoker) 80.0 100.0
43 Spirometry (at least one electronic record) 70.0 100.0
HbA1c glycosylated hemoglobin, ACE-I Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker
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Fig. 1 Flowchart ofGP recruitment andparticipation
for separately. Word root searches were also used,
e. g. “simva” and “statin”. All searching results were
summed up manually; however, compound terms
(e. g. simvastatin) were counted twice and were there-
fore searched additionally and then subtracted. For
the most used software (EHR 2), an additional data
filtering module was acquired for the study period,
which allowed several search terms to be used and
to combine them by an operator and counting every
patient only once; however, the number of search
terms was limited by a maximum number of charac-
ters. Diagnoses could also be searched as permanent
diagnoses. Search profiles could be saved and used
for the next data extraction with adaptation of the
search interval. In EHR 3, extraction of prescriptions
was only possible if a diagnosis was recorded within
the last 3 months. Otherwise, the patient was not
counted. The company producing EHR 4 provided
searching profiles for Microsoft® Access 2010, where
data had to be transferred and anonymized allowing
extraction without any restraints. The EHR 5 only al-
lowed the extraction of the prevalences; therefore, all
other QIs resulted as missing values in the respective
GPs. The filter allowed only data within a specific year
to be extracted and not within the last 15 months, as
defined in our study; however, we assumed that this
extraction process did not overlook patients, as pa-
tients with chronic illnesses usually visit their GP at
least once a year.
Due to the heterogeneous and limited technical op-
portunities, standardization of the data extraction was
not possible. To achieve a minimum of standard-
ization, search terms for diagnoses and medications
were listed for data extraction. Three GPs using EHR 1
and 3 were excluded from data analysis because ex-
traction was not possible according to the definition
of QIs.
Ethics
The ethics committee of the province of Salzburg gave
an ethics waiver because no individual patient data
were collected or processed.
Intervention
After each data extraction all GPs received graphic and
written information about their fulfilment of QIs in
percentages (self-audit) and anonymously the results
of their colleagues (benchmarking). Furthermore, the
medians of the region and the quality standards pre-
viously defined (acceptable and ideal level of perfor-
mance for all QIs) were provided. The report was sent
per postal delivery.
Regional quality circles of the participating GPs
with support of the project team were established
after the first data collection to discuss results, differ-
ences between regions and physicians and to elab-
orate possibilities for improvement in chronic care.
Quality circles were conducted on average once or
twice a year, attendance was optional. Two transna-
tional quality circles (September 2013 and May 2014)
were additionally organized for all GPs from both
regions to enhance networking between the coun-
tries.
Data analysis
Benchmarking analysis was conducted manually us-
ing Microsoft® Excel® 2010.
Calculation of the quality score: the quality score
was developed by the project team as follows and cal-
culated using IBM® SPSS® statistics version 20.0. We
considered all quality indicators except prevalence
rates, as we could not find representative Austrian
comparative data for all eight diseases targeted by
IQuaB and the prevalence could be biased by over-
diagnosis or underdiagnosis (in contrast to the other
QIs that are generally better the higher they are).
Therefore, 35 QIs were included in the calculation of
the quality score. We assigned between zero and five
points per QI. Point assignment for each indicator
was based on the median at baseline: the median mi-
nus 10% was the minimum to achieve one point. If
the median fell below 20%, 10% was the minimum to
achieve one point (e. g. recording of smoking behavior
in diabetes). No point was awarded if the calculated
minimum target value was not reached. For each ad-
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Table 2 Theuseofelectronichealth recordsamongpartic-
ipatingGPs (statusasof 2012)
Electronic health records Number of surgeries (GPs)
EHR 1 1 (1)
EHR 2 11 (12)
EHR 3 2 (2)
EHR 4 3 (3)
EHR 5 3 (3)
Fig. 2 Longitudinal analysis of thequality score. Medianqual-
ity score2012: 62.0points (Q1–Q3: 19.5–99.5),medianquality
score2013: 97.5points (Q1–Q3: 55.3–119.0),medianquality
score2014: 84.0points (Q1–Q3: 69.5–119.8)
ditional 5% that were reached, one further point was
added. For simplification, percentages were rounded.
For each GP, one individual quality score was calcu-
lated by summation of the points of the single QIs.
Quality scores could not be calculated for the three
GPs using EHR 5, from which only prevalence rates
could be extracted.
Missing data and exclusion of data: if prevalence
rates were 0, we excluded all other QIs depending on
the prevalence. As the data extraction was performed
manually, some errors in the data extraction process
occurred. In the cases where the mistakes could not
be corrected during the data extraction process or af-
terwards, values that could not be valid (e. g. percent-
ages that exceeded 100%) were excluded.
Statistical analysis was carried out using the soft-
ware package IBM® SPSS® statistics version 20.0.
Units of analyses were GPs. To check for normal dis-
tribution, the Kolmogorov Smirnov test was used. As
data were skewed, we performed Wilcoxon signed-
rank tests for longitudinal analysis. Significance level
was set at 5% (p < 0.05). Tests were carried out with
the quality score and the single QIs.
Results
Participating physicians and EHR
Of the 114 surgeries (133 GPs) invited to participate
in Salzburg, 26 surgeries (27 GPs) signed informed
consent for the study (participation rate of surg-
eries 22.8%), 19 surgeries (20 GPs) finished the study
(Fig. 1). 30.0% of the participating GPs were female,
50.0% of the participating GPs surgeries were located
in the province Pongau and 50.0% were located in
the province Pinzgau. The mean age of participat-
ing physicians was 52.9 years. All but one of the
participating GPs worked in single-handed practices.
The participating GPs were of a similar sex and re-
gional distribution as all invited GPs (26.3% female,
51.1% Pongau). We could not obtain any further data
from non-participating GPs so that a more detailed
comparison was not possible.
The distribution of the EHRs used by the GPs is
listed in Table 2.
Quality score
Quality score point assignments and cut-offs for the
considered 35 QIs are shown in Table 3. In total,
175 points were achievable (up to 5 points for each
QI). The median quality score (Fig. 2) increased sig-
nificantly from baseline to the first follow-up (p =
0.002) and decreased not significantly between first
and second follow-up (p = 0.535); however, improve-
ment from baseline to second follow-up remained sig-
nificant (p = 0.003).
Explorative analysis of individual QIs
A significant increase of prevalence was observed
in DM from the first to the second follow-up and
over the study period in HT, AF and COPD. The BMI
recordings increased enormously but not significantly
from baseline to first follow-up in HT and CHD and
decreased significantly from first to second follow-
up. In PAD and CHF, the percentage of patients with
BMI recordings increased significantly from baseline
to first follow-up and declined afterwards not signif-
icantly. Blood pressure measurements increased in
DM, CHD and PAD significantly from baseline to first
follow-up and additionally from baseline to second
follow-up in CHD and PAD. Registration of smok-
ing behavior increased significantly from baseline to
first and second follow-up in all concerning diseases
but HT. The percentage of creatinine measurement
did not change significantly. The HbA1c measure-
ments, HbA1c values below 7.5% and metformin
prescriptions if HbA1c ≥ 7.5% improved slightly but
not significantly over the study period. Spirometry
in patients with COPD increased significantly from
baseline to second follow-up, although there was
a significant decline from first to second follow-up.
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Table 3 Spreadsheet for thecalculationof thequality score (point assignmentbasedon themedianvalueatbaseline for each
quality indicator)
Median (%) 0 point 1 point 2 points 3 points 4 points 5 points
Diabetes mellitus type 2
Body mass index (recorded within last 15 months) 18.4 <10 10.0–14.9 15.0–19.9 20.0–24.9 25.0–29.9 ≥30
Blood pressure (recorded within last 15 months) 56.9 <45 45.0–49.9 50.0–54.9 55.0–59.9 60.0–64.9 ≥65
Registration of smoking behavior (smoker or non-smoker) 4.1 <10 10.0–14.9 15.0–19.9 20.0–24.9 25.0–29.9 ≥30
Creatinine measurement (done within last 15 months) 46.8 <35 35.0–39.9 40.0–44.9 45.0–49.9 50.0–54.9 ≥55
HbA1c measurement (done within last 9 months) 55.4 <45 45.0–49.9 50.0–54.9 55.0–59.9 60.0–64.9 ≥65
HbA1c < 7.5% (any value within last 9 months) 74.0 <65 65.0–69.9 70.0–74.9 75.0–79.9 80.0–84.9 ≥85
Metformin prescription (within last 3 months) if HbA1c ≥
7.5 % (any value within last 9 months)
53.8 <45 45.0–49.9 50.0–54.9 55.0–59.9 60.0–64.9 ≥65
Hypertension
Body mass index (recorded within last 15 months) 16.3 <10 10.0–14.9 15.0–19.9 20.0–24.9 25.0–29.9 ≥30
Blood pressure (recorded within last 15 months) 50.6 <40 40.0–44.9 45.0–49.9 50.0–54.9 55.0–59.9 ≥60
Registration of smoking behavior (smoker or non-smoker) 5.8 <10 10.0–14.9 15.0–19.9 20.0–24.9 25.0–29.9 ≥30
Creatinine measurement (done within last 15 months) 41.0 <30 30.0–34.9 35.0–39.9 40.0–44.9 45.0–49.9 ≥50
Coronary heart disease
Body mass index (recorded within last 15 months) 24.4 <15 15.0–19.9 20.0–24.9 25.0–29.9 30.0–34.9 ≥35
Blood pressure (recorded within last 15 months) 53.5 <45 45.0–49.9 50.0–54.9 55.0–59.9 60.0–64.9 ≥65
Registration of smoking behavior (smoker or non-smoker) 4.5 <10 10.0–14.9 15.0–19.9 20.0–24.9 25.0–29.9 ≥30
Statin prescription (within last 3 months) 36.9 <25 25.0–29.9 30.0–34.9 35.0–39.9 40.0–44.9 ≥45
Beta-blocker prescription (within last 3 months) 30.5 <20 20.0–24.9 25.0–29.9 30.0–34.9 35.0–39.9 ≥40
Prescription of antithrombotic therapy (within last 8 months) 69.7 <60 60.0–64.9 65.0–69.9 70.0–74.9 75.0–79.9 ≥80
Cerebrovascular disease
Body mass index (recorded within last 15 months) 24.2 <15 15.0–19.9 20.0–24.9 25.0–29.9 30.0–34.9 ≥35
Blood pressure (recorded within last 15 months) 52.3 <40 40.0–44.9 45.0–49.9 50.0–54.9 55.0–59.9 ≥60
Registration of smoking behavior (smoker or non-smoker) 5.6 <10 10.0–14.9 15.0–19.9 20.0–24.9 25.0–29.9 ≥30
Statin prescription (within last 3 months) 29.6 <20 20.0–24.9 25.0–29.9 30.0–34.9 35.0–39.9 ≥40
Prescription of antithrombotic therapy (within last 8 months) 65.0 <55 55.0–59.9 60.0–64.9 65.0–69.9 70.0–74.9 ≥75
Peripheral arterial disease
Body mass index (recorded within last 15 months) 25.0 <15 15.0–19.9 20.0–24.9 25.0–29.9 30.0–34.9 ≥35
Blood pressure (recorded within last 15 months) 47.2 <35 35.0–39.9 40.0–44.9 45.0–49.9 50.0–54.9 ≥55
Registration of smoking behavior (smoker or non-smoker) 0.0 <10 10.0–14.9 15.0–19.9 20.0–24.9 25.0–29.9 ≥30
Statin prescription (within last 3 months) 34.0 <25 25.0–29.9 30.0–34.9 35.0–39.9 40.0–44.9 ≥45
Prescription of antithrombotic therapy (within last 8 months) 74.2 <65 65.0–69.9 70.0–74.9 75.0–79.9 80.0–84.9 ≥85
Chronic heart failure
Body mass index (recorded within last 15 months) 20.0 <10 10.0–14.9 15.0–19.9 20.0–24.9 25.0–29.9 ≥30
Blood pressure (recorded within last 15 months) 60.0 <50 50.0–54.9 55.0–59.9 60.0–64.9 65.0–69.9 ≥70
ACE-I or ARB prescription (within last 3 months) 43.8 <35 35.0–39.9 40.0–44.9 45.0–49.9 50.0–54.9 ≥55
Beta-blocker prescription (within last 3 months) 29.4 <20 20.0–24.9 25.0–29.9 30.0–34.9 35.0–39.9 ≥40
Atrial fibrillation
Blood pressure (recorded within last 15 months) 57.5 <45 45.0–49.9 50.0–54.9 55.0–59.9 60.0–64.9 ≥65
Prescription of antithrombotic therapy (within last 8 months) 67.8 <60 60.0–64.9 65.0–69.9 70.0–74.9 75.0–79.9 ≥80
Chronic obstructive pulmonary disease
Registration of smoking behavior (smoker or non-smoker) 13.1 <10 10.0–14.9 15.0–19.9 20.0–24.9 25.0–29.9 ≥30
Spirometry (at least one electronic record) 11.7 <10 10.0–14.9 15.0–19.9 20.0–24.9 25.0–29.9 ≥30
HbA1c glycosylated hemoglobin, ACE-I Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker
The ACE-I or ARB prescriptions as well as prescrip-
tions of antithrombotic agents did not alter in any of
the diseases concerned. Beta blocker prescriptions in-
creased significantly in CHD patients but not in CHF
patients. Statin prescriptions in CHD improved sig-
nificantly over the study period but did not change in
CBVD and in PAD. The results for all QIs are shown in
Table 4.
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Table 4 Resultsof the longitudinal analysis of all quality indicators (median, first and thirdquartile inpercentagesandp-values)
(italic numbers significant increase,bold numbers significantdecrease)
Quality indicator 2012 2013 2014 p-value
Median Q1 Q3 Median Q1 Q3 Median Q1 Q3 2012–2013 2013–2014 2012–2014
Diabetes mellitus type 2
Prevalence 3.9 2.5 5.1 4.3 2.6 5.4 4.8 3.4 5.7 0.469 0.018 0.117
Body mass index (recorded within last
15 months)
18.4 6.5 69.1 24.0 9.7 77.2 22.7 3.2 59.5 0.075 0.110 0.534
Blood pressure (recorded within last
15 months)
56.9 33.0 76.6 62.5 32.3 80.8 68.9 31.0 87.0 0.008 0.605 0.125
Registration of smoking behavior
(smoker or non-smoker)
4.1 0.0 9.7 12.9 8.0 22.0 20.0 9.1 22.7 0.011 0.799 0.007
Creatinine measurement (done within
last 15 months)
46.8 31.9 72.5 55.9 37.2 78.3 60.8 36.2 71.8 0.255 0.501 0.717
HbA1c measurement (done within last
9 months)
55.4 39.5 77.4 54.3 40.5 78.8 62.9 50.3 77.9 0.826 0.433 0.331
HbA1c < 7.5% (any value within last
9 months)
74.0 31.1 93.5 81.0 54.8 89.1 83.6 60.9 89.6 0.768 0.173 0.515
Metformin prescription (within last
3 months) if HbA1c ≥ 7.5 % (any
value within last 9 months)
53.9 19.8 82.1 78.6 45.1 87.3 63.2 38.1 85.2 1.000 0.575 0.859
Hypertension
Prevalence 14.3 9.6 16.3 15.4 12.8 19.3 15.9 13.6 20.0 0.039 0.267 0.003
Body mass index (recorded within last
15 months)
16.3 6.2 53.1 42.7 12.3 60.1 22.2 5.0 49.5 0.182 0.006 0.155
Blood pressure (recorded within last
15 months)
50.6 39.1 75.3 67.9 37.9 85.8 71.5 34.3 86.6 0.583 0.691 0.754
Registration of smoking behavior
(smoker or non-smoker)
5.8 0.8 11.2 18.0 11.5 23.1 13.9 7.0 24.9 0.110 0.169 0.114
Creatinine measurement (done within
last 15 months)
41.0 18.5 52.0 41.6 25.8 57.9 38.1 15.6 50.3 0.469 0.163 0.148
Coronary heart disease
Prevalence 2.9 1.3 4.9 2.9 1.8 4.5 2.9 1.8 4.5 0.841 0.717 0.936
Body mass index (recorded within last
15 months)
24.4 6.5 51.7 44.9 6.7 61.6 20.2 3.3 53.7 0.062 0.034 0.937
Blood pressure (recorded within last
15 months)
53.5 44.8 77.0 59.9 43.9 86.4 65.9 47.5 86.8 0.041 0.173 0.008
Registration of smoking behavior
(smoker or non-smoker)
4.6 0.0 5.7 20.0 10.2 28.7 23.6 12.9 31.8 0.011 0.959 0.005
Statin prescription (within last
3 months)
36.9 27.8 48.7 43.8 30.9 57.4 43.5 29.5 58.4 0.096 0.551 0.035
Beta-blocker prescription (within last
3 months)
30.5 22.8 40.1 41.5 32.7 55.7 42.8 33.3 64.7 0.005 0.221 0.001
Prescription of antithrombotic therapy
(within last 8 months)
69.7 57.3 75.9 68.7 56.3 77.6 66.4 58.9 80.3 0.177 0.975 0.245
Cerebrovascular disease
Prevalence 1.3 0.9 2.0 1.5 1.0 1.9 1.4 1.0 2.0 0.295 0.520 0.469
Body mass index (recorded within last
15 months)
24.2 2.3 49.9 45.4 13.1 54.0 23.6 10.4 50.9 0.136 0.158 0.638
Blood pressure (recorded within last
15 months)
52.3 39.0 73.3 66.0 31.7 81.5 54.0 25.0 71.4 0.272 0.198 0.422
Registration of smoking behavior
(smoker or non-smoker)
5.6 0.0 11.1 24.9 11.1 43.6 13.2 7.6 31.3 0.008 0.074 0.028
Statin prescription (within last
3 months)
29.6 17.3 36.5 28.7 22.0 40.3 28.6 21.4 40.1 0.875 0.875 0.552
Prescription of antithrombotic therapy
(within last 8 months)
65.0 56.0 71.1 66.7 57.9 75.6 64.6 50.0 70.0 0.552 0.331 0.433
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Table 4 (Continued)
Quality indicator 2012 2013 2014 p-value
Peripheral arterial disease
Prevalence 0.6 0.3 0.9 0.5 0.3 0.9 0.6 0.3 0.9 0.647 0.831 0.913
Body mass index (recorded within last
15 months)
25.0 7.7 52.3 38.7 8.5 56.8 20.0 0.0 58.0 0.047 0.328 0.248
Blood pressure (recorded within last
15 months)
47.2 32.5 77.1 67.4 34.0 89.7 76.0 43.2 84.6 0.026 1.000 0.033
Registration of smoking behavior
(smoker or non-smoker)
0.0 0.0 20.0 41.9 19.4 58.4 41.7 18.2 60.0 0.008 0.093 0.013
Statin prescription (within last
3 months)
34.0 19.0 50.0 38.8 28.7 55.4 39.6 35.2 52.8 0.084 0.875 0.117
Prescription of antithrombotic therapy
(within last 8 months)
74.2 63.5 80.3 82.6 71.3 93.0 77.4 71.5 88.4 0.050 0.158 0.507
Chronic heart failure
Prevalence 0.6 0.2 0.8 0.5 0.3 1.2 0.5 0.3 1.0 0.198 0.198 0.841
Body mass index (recorded within last
15 months)
20.0 0.0 57.6 33.3 17.7 73.1 31.3 8.9 65.7 0.011 0.646 0.374
Blood pressure (recorded within last
15 months)
60.0 26.9 86.4 77.6 55.9 95.7 82.9 55.7 95.9 0.182 0.917 0.155
ACE-I or ARB prescription (within last
3 months)
43.8 18.7 60.5 50.0 43.0 64.1 51.1 32.7 59.1 0.374 0.583 0.445
Beta-blocker prescription (within last
3 months)
29.4 9.8 48.5 42.3 33.3 60.0 47.2 30.8 60.2 0.093 0.859 0.074
Atrial fibrillation
Prevalence 1.6 1.0 2.8 2.3 1.7 3.0 2.6 1.3 3.1 0.064 0.227 0.027
Blood pressure (recorded within last
15 months)
57.5 38.7 76.2 63.9 53.2 83.8 64.1 42.3 75.6 0.470 0.551 0.551
Prescription of antithrombotic therapy
(within last 8 months)
67.8 58.5 76.3 75.6 70.7 79.6 75.0 64.8 79.1 0.074 0.683 0.140
Chronic obstructive pulmonary disease
Prevalence 1.8 1.3 3.3 1.9 1.5 3.7 2.1 1.5 4.1 0.044 0.126 0.020
Registration of smoking behavior
(smoker or non-smoker)
13.1 2.7 39.6 56.0 38.6 69.0 52.4 39.1 58.3 0.011 0.594 0.007
Spirometry (at least one electronic
record)
11.7 3.7 17.7 45.1 9.5 82.7 42.2 11.6 83.2 0.018 0.036 0.018
HbA1c glycosylated hemoglobin, ACE-I Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker
Achievement of quality standards
QIs at baseline were below the set quality stan-
dards (acceptable level of performance) except of
the median percentage of HbA1c < 7.5% in DM that
amounted between 70 and 90% and remained in
this range. Prescription of antithrombotic therapy in
PAD patients and metformin prescriptions achieved
the quality standards in the first follow-up, but fell
below again at the second follow-up. Blood pressure
measurements within the last 15 months in patients
with CHF were rising throughout the study period
and achieved the quality standards at the first and
second follow-up. Measurements of blood pressure in
HT and PAD as well as DM prevalence achieved the
determined quality standard at the second follow-up.
The percentage of HbA1c measurements were close
below the set level of acceptable performance and
achieved it at the second follow-up.
Discussion
Summary and interpretation of findings
Baseline performance as measured by the quality
score was low. Improvement of the quality score
was remarkable in the period between baseline and
first follow-up. Taking a closer look to the individual
QIs, we can observe that especially documentation
indicators increased (e. g. registration of smoking
behavior), while prescriptions only changed to some
extent. The only measured intermediate outcome
parameter (HbA1c < 7.5%) increased slightly but
not significantly; however, this indicator was already
at a relatively high level at baseline. While in the
period between baseline and first follow-up strong
improvements were reached, in the period from first
to second follow-up improvements slowed down or
quality of care remained at the same level in many
cases. Some QIs were even regressive between first
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and second follow-up; however, most of the signifi-
cant improvements achieved up until the first follow-
up remained significant between baseline and the
second follow-up. Wide spans between first and third
quartile indicated large differences among GPs.
The low grade of QI fulfilment in our samplemay be
related to different possible scenarios: firstly, clinical
actions were actually not performed, secondly, clinical
actions were performed but were not documented in
the EHR and thirdly, clinical actions were performed
and documented but it was not possible to extract
the information from the EHR. We assume that all
three explanatory models played a role in our sample
but a case-based assignment was not possible. Even
medications that are usually electronically prescribed
by a GP may be prescribed by other medical special-
ists intermittently or prescribed by hand during home
visits. In this case, the medication does not appear
in the EHR despite regular prescription. Another ex-
ample is that we assume that many GPs particularly
in rural areas know whether their patients smoke and
are aware of the risk factor but often do not system-
atically record smoking behavior and thus have “low
performance” in the benchmarking. Furthermore, the
lack of possibility for exception reporting as it is pos-
sible in the UK (e.g. deliberate exclusion of patients
as in the case of contraindications) might have con-
tributed to the low prescription rates. Exclusion of
patients leads to a lower denominator in the calcula-
tion of the respective QI and thus, to a higher percent-
age of achievement. The fact that we did not incen-
tivise the achievement of quality standards potentially
strengthens the low grade of fulfilment. The remark-
able improvements between baseline and first follow-
up could be due to increased awareness and docu-
mentation on the side of GPs but could also reflect
a true improvement of performance.
We considered possible factors leading to lower QI
fulfilment, which do not depend on the performance
of the GPs (e. g. known percentages of contraindica-
tions or patient non-compliance), at the beginning of
the study by setting the levels of the target values be-
low 100% according to the standards used by Health
Search [13]. Nevertheless, the target levels were only
occasionally achieved. Hence, besides performance
and documentation factors, also the levels of the qual-
ity standards might be a point of discussion.
Results in the context of similar studies and quality
programs
The IQuaB results can be only partially compared to
other Austrian data as there is a lack of representative
epidemiological data and QIs are not used regularly
in Austrian primary care. Epidemiological surveys of
type 2 DM estimate its prevalence to be approximately
8.0–9.0% including 2.0–3.0% patients as yet unde-
tected [21]. In our sample the prevalence rates were
between 3.9 and 4.8%. As our study was limited to two
rural regions of Salzburg, the difference is possibly re-
lated to geographic factors (or to the abovementioned
explanatory models). A study conducted in 23 GP
surgeries and 1 practice of internal medicine found
higher rates of HbA1c measurements (74% within last
6 months) and serum creatinine measurements (84%
within last 12 months). The number of patients with
good HbA1c control was similar; however, the sample
was limited to geriatric patients [22]. The prevalence
of COPD was 7.5% in general practices in Salzburg
(Austria) in a population aged 40 years or older. Only
one out of five patients suffering from COPD reported
a prior COPD diagnosis by the physician. This fact was
interpreted as underdiagnosing [23]. In our study, the
prevalence of COPD was between 1.8 and 2.1% in the
general population, which could be interpreted that
COPD is also underdiagnosed in our sample. Among
the subjects from another study in Salzburg, who re-
ported a prior physician diagnosis of COPD, 68% re-
ported a lung function test at some time in the past
[24], whereas in our sample spirometry was docu-
mented only in 12–45% of affected patients. Some
85% of patients in the heart failure registry in Austria
(n = 1648 patients in ambulances of hospitals and of
specialists practices) received ACE-I/ARB and 79% re-
ceived beta blockers [25]. Our results weremuch lower
(ACE-I/ARB 44–51% and beta blockers 29–47%).
In England, comprehensive quality initiatives
started several years before we conducted our study
in Austria and Italy. After introduction of the QOF
quality improvement in UK was remarkable 1 year
later but slowed down after the first year and stalled
when targets were reached [26]. Similarly, our results
showed a high increase between baseline and first
follow-up but did not improve further between first
and second follow-up.
Limitations
Precondition for measurement of QIs is the documen-
tation and registration of diagnoses and services in
the EHR. Structural challenges made the extraction of
valid and reliable data difficult [27]. In Austrian pri-
mary care, most parameters are not entered in a stan-
dardized way and functions of filtering systems in
EHRs are limited. Thus, values have to be interpreted
cautiously. Furthermore, the technical restrictions al-
lowed applying only a limited number of QIs. As there
is no list system in Austria, the calculation of preva-
lence in the general population is only an extrapola-
tion and QIs using prevalence are not reliable.
The quality score was developed with available data
for comparison in retrospect based on the median
value of each QI. Scoring was not based on the prede-
fined quality standards because the percentages of QI
fulfilment achieved were in most cases considerably
below the standards and therefore, the quality scores
would have resulted in very small numbers and depic-
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tion of changes would have been limited due to the
floor effect.
Another limitation is that we mainly assessed pro-
cess indicators and only one surrogate outcome and
the quality score focuses on indicators of documen-
tation quality. Although it seems to adequately re-
flect the progress of performance in our data at the
level of GPs, the quality score does not mirror qual-
ity in its wide spectrum. The QIs in general depict
only a part of real life medical care and they are not
able to comprise the complexity of healthcare, espe-
cially within the multidimensional approach of family
medicine [28].
We could not provide evidence on patient-relevant
outcomes, such as preventing amputation, hospital-
ization or mortality. Up to now it remains unclear
whether and how QI-driven programs influence pa-
tient-relevant outcomes. In the UK high performance
in the QOF was shown to be slightly to moderately
associated with good patient experience [29, 30] but
a rigorous proof of a relevant effect on outcome is not
yet available. A small association between QOF scores
and emergency admissions [31, 32] and mortality [31]
was found but results were inconsistent [31, 32]. An-
other study did not find a relationship between incen-
tive payments and lives saved or quality adjusted life
years [33].
Our results are not representative for Austria be-
cause GPs were recruited in specific regions, the sam-
ple is small and may over-represent highly motivated
GPs. Generalizability of our results is therefore lim-
ited. Multiple testing of QIs has led to a higher chance
of significant results; therefore, the interpretation of
the improvement of single QIs has to be confirmed in
further studies. As our study design did not contain
a control group, we cannot exclude other effects on
the changes beside the intervention.
Barriers experienced
We perceived several barriers during the attempt to
implement our quality improvement program. Struc-
tured quality management is relatively new in ambu-
latory care in Austria and viewed with scepticism. The
first barrier, therefore, was general participation. Low
participation of GPs is probably the result of a lack
of awareness, of scepticism regarding the potential
achievements of structured quality work as well as of
a high workload. The GPs’ workload was also one of
the most frequently given reasons for not attending
the quality circles. The second barrier is that Aus-
trian EHRs are not intended to measure QIs. Docu-
mentation in EHRs in Austrian general practices is un-
structured and diagnoses and reasons for consultation
are not coded. Several EHRs with heterogeneous soft-
ware functions are in use. Missing software functions,
e. g. for standardized entry of smoking behavior, blood
pressure or laboratory values are prevalent which lead
to individual solutions in each surgery. In this situa-
tion, accurate data administration is time-consuming
and does not appear to be beneficial for daily work
at first sight; therefore, in IQuaB, data extraction had
to be performed manually by the project staff, which
was technically challenging and time-consuming and
thus it may have been error-prone with no possibility
to estimate the magnitude of this error. All these facts
impeded a standardized, valid data extraction [27].
Implications for the future
Awareness for structured quality management (e.g.
measurement of QIs, benchmarking and quality cir-
cles) should be increased in companies developing
EHRs, stakeholders as well as in providers. A quality
strategy for general practice in Austria would be ad-
vantageous to increase awareness and to take actions
for quality improvement. Although QIs show themen-
tioned limitations, they are important instruments
for assessing and quantifying quality [6]; improved
software functions would allow more dimensions
of quality to be analyzed, including (intermediate)
outcome parameters. Information technology (IT)
solutions should provide an intuitive user interface
and relieve GPs’ daily work by facilitating standardized
documentation and coding (e. g. of diagnoses, medi-
cation, laboratory values, anthropometrical data and
smoking habits), by providing information (e. g. up
to date guidelines, diagrams of medical parameters
and benchmarking with colleagues), by supporting
decisions using reminders and alerts (e. g. medication
interactions) and by importing data from relevant
providers, such as laboratory results. A reasonable
documentation of medical data should be assured
and ideally analysis of epidemiological data (e. g.
prevalence, age, sex, diagnostic and therapy data)
should be facilitated. The possibility of a central,
standardized and valid data acquisition and process-
ing is an essential precondition for quality promotion
based on medical data. A list system in Austria could
enable epidemiological studies and show real preva-
lence data.
Trainings for GPs in (software-assisted) quality
management could be helpful to increase awareness.
The mentioned barriers should be taken into account
in future quality programs and IT solutions.
Conclusion
This study was the first to implement self-auditing,
benchmarking and quality circles targeted at QIs
among GPs in Austria and to assess the feasibility of
such a program. Low baseline performance empha-
sizes the importance of quality improvement initia-
tives in Austria. We observed strong improvements in
the first study period that underline the effectiveness
of our intervention and show that improvements are
achievable within short periods. Although there are
several limitations, our work can form the basis to
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develop and refine quality promotion initiatives. We
identified weak structures for implementing a QI-
driven program so that IT solutions and the use of
coding systems are required to realize a national pro-
gram based on QIs. In this case influencing factors
(e. g. patient sex and age) could be taken into consid-
eration and used additionally for risk adjustment in
the benchmarking. We recommend periodically mod-
ifying the QIs because the strongest improvements are
achieved within the first 9 months after implemen-
tation. Further international, long-term prospective
studies are required to set evidence-based quality
standards and to confirm the association between
improvement of QIs and patient-relevant outcomes,
such as preventing hospitalization and reducing mor-
tality.
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